Bausch Health Companies Stock Analysis

Bausch Stock Analysis Notes

About 71.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 0.02. Bausch Health Companies recorded a loss per share of 0.67. The entity last dividend was issued on the 10th of November 2010. The firm had 2:1 split on the 5th of October 2000. Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. Bausch Health Companies Inc. was founded in 1983 and is headquartered in Laval, Canada. BAUSCH HEALTH operates under Drug Manufacturers - Specialty Generic classification in Canada and is traded on Toronto Stock Exchange. It employs 21100 people. For more info on Bausch Health Companies please contact the company at 514 744 6792 or go to https://www.bauschhealth.com.

Bausch Health Companies Investment Alerts

Bausch Largest EPS Surprises

View All Earnings Estimates

Bausch Health Thematic Classifications

Bausch Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.11 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bausch Health's market, we take the total number of its shares issued and multiply it by Bausch Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Bausch Profitablity

The company has Profit Margin (PM) of (0.02) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.22 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.22.

Management Efficiency

Bausch Health Companies has return on total asset (ROA) of 0.0415 % which means that it generated a profit of $0.0415 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (23.0454) %, meaning that it generated substantial loss on money invested by shareholders. Bausch Health's management efficiency ratios could be used to measure how well Bausch Health manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of November 2024, Return On Equity is likely to grow to 0.61, though Return On Tangible Assets are likely to grow to (0.06). At this time, Bausch Health's Other Current Assets are very stable compared to the past year. As of the 25th of November 2024, Total Current Assets is likely to grow to about 5.9 B, while Total Assets are likely to drop about 14.9 B.

Technical Drivers

As of the 25th of November, Bausch Health shows the Downside Deviation of 1.76, risk adjusted performance of 0.1461, and Mean Deviation of 2.03. Bausch Health Companies technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Bausch Health Companies Price Movement Analysis

Bausch Health Outstanding Bonds

Bausch Health Predictive Daily Indicators

Bausch Health Forecast Models

Bausch Health's time-series forecasting models are one of many Bausch Health's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bausch Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Bausch Health prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bausch shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Bausch Health. By using and applying Bausch Stock analysis, traders can create a robust methodology for identifying Bausch entry and exit points for their positions.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.